Sabba Stephen L
SEC Form 4 insider trading activity
Sabba Stephen L has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Jun 18, 2026.
On the most recent filing, Sabba Stephen L is listed as Director at LIGAND PHARMACEUTICALS INC. Inside the rolling window, Sabba Stephen L reported no open-market purchases and 3 open-market sales totaling $1.2M in LGND. The largest disclosed transaction in the window is a sale of 2,145 LGND shares on Jun 16, 2026, worth $545K.
Companies traded
Other insiders at LGND
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Sabba Stephen L made?
Sabba Stephen L has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Sabba Stephen L trade?
Sabba Stephen L has filed SEC Form 4 disclosures for 1 company, including LGND.
When was Sabba Stephen L's most recent SEC Form 4 filing?
Sabba Stephen L's most recent SEC Form 4 filing on Tracefour is dated Jun 18, 2026.
What is Sabba Stephen L's total buy and sell value in the current window?
Inside the rolling retention window, Sabba Stephen L bought $0 and sold $1.2M based on SEC Form 4 filings.
What was Sabba Stephen L's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,145 LGND shares on 2026-06-16, worth $545K, per SEC Form 4 filings.